![Qiong Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Qiong Liu
Direttore/Membro del Consiglio presso Wuxi Langshion Lightweight Technology Co., Ltd.
Profilo
Qiong Liu currently works at Wuxi Langshion Lightweight Technology Co., Ltd., as Director from 2021.
Posizioni attive di Qiong Liu
Società | Posizione | Inizio |
---|---|---|
Wuxi Langshion Lightweight Technology Co., Ltd.
![]() Wuxi Langshion Lightweight Technology Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Wuxi Langshion Lightweight Technology Co., Ltd. is a leading biologics technology platform that offers end-to-end solutions for discovering, developing, and manufacturing biologics from concept to commercial manufacturing. The company is based in Wuxi, China. Wuxi Biologics is committed to environmental, social, and governance (ESG) responsibilities and aims to become an ESG leader in biologics manufacturing. It specializes in viral vaccines process development, microbial services, and solutions. The Chinese company uses next-generation clean biomanufacturing technologies and cleaner energy sources. It has also established an ESG committee led by the CEO, Yang Chen, who founded the company in 2013 and has been the CEO since then. | Direttore/Membro del Consiglio | 24/12/2021 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Wuxi Langshion Lightweight Technology Co., Ltd.
![]() Wuxi Langshion Lightweight Technology Co., Ltd. Investment Trusts/Mutual FundsMiscellaneous Wuxi Langshion Lightweight Technology Co., Ltd. is a leading biologics technology platform that offers end-to-end solutions for discovering, developing, and manufacturing biologics from concept to commercial manufacturing. The company is based in Wuxi, China. Wuxi Biologics is committed to environmental, social, and governance (ESG) responsibilities and aims to become an ESG leader in biologics manufacturing. It specializes in viral vaccines process development, microbial services, and solutions. The Chinese company uses next-generation clean biomanufacturing technologies and cleaner energy sources. It has also established an ESG committee led by the CEO, Yang Chen, who founded the company in 2013 and has been the CEO since then. | Miscellaneous |
- Borsa valori
- Insiders
- Qiong Liu